About the Rosacea and Related Disorders Session
Rosacea is a chronic inflammatory skin condition that primarily affects the face, causing redness, flushing, visible blood vessels, and in some cases, pustules or bumps resembling acne. While the exact cause of rosacea is unknown, factors such as genetics, abnormal immune response, and environmental triggers are believed to play a role. Common triggers include sunlight, stress, certain foods, alcohol, and temperature extremes. There are several subtypes of rosacea, including erythematotelangiectatic rosacea (characterized by persistent facial redness and visible blood vessels), papulopustular rosacea (involving acne-like bumps and pustules), phymatous rosacea (resulting in thickened skin and enlargement of facial features), and ocular rosacea (affecting the eyes, causing irritation, redness, and swelling). Diagnosis of rosacea is based on clinical presentation, medical history, and exclusion of other skin conditions. While there is no cure for rosacea, various treatments can help manage symptoms and prevent flare-ups. These may include topical and oral medications, laser therapy, and lifestyle modifications. In addition to rosacea, related disorders such as perioral dermatitis (inflammatory facial rash around the mouth), seborrheic dermatitis (chronic inflammation of oily areas of the skin), and demodicosis (infestation of hair follicles by the Demodex mite) can present with similar symptoms and may require different treatment approaches. Managing rosacea and related disorders involves a combination of medical interventions, avoidance of triggers, and skincare practices tailored to individual needs. Regular follow-up with a dermatologist is essential for monitoring symptoms and adjusting treatment as needed to optimize outcomes and improve quality of life.
Featured Speakers — Rosacea and Related Disorders 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Rosacea and Related Disorders Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Rosacea and Related Disorders Conference 2027
Present Your Research
Oral and poster slots for original Rosacea and Related Disorders work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Rosacea and Related Disorders research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Rosacea and Related Disorders track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Rosacea and Related Disorders Conference 2027 — FAQs
What is the Rosacea and Related Disorders track at IDC 2027?
The Rosacea and Related Disorders track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Rosacea and Related Disorders. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Rosacea and Related Disorders sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Rosacea and Related Disorders are all welcome — whether presenting or attending.
Can I present my research in the Rosacea and Related Disorders track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Rosacea and Related Disorders sessions?
Yes. IDC 2027 is a hybrid conference — attend the Rosacea and Related Disorders track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

